Study links Alport genetics to kidney symptoms
Part of Genetic & congenital, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study looks at how specific genetic changes (genotypes) relate to kidney problems and urine blood findings in people with Alport syndrome. It may help doctors predict disease course and tailor care, though it may not involve new treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be any age (including children and older adults, up to age 99)
- Have a history of blood in the urine from kidney problems (renal hematuria)
- Have had Alport syndrome in your family or in your own history
- Be able to sign the study consent form
- Have enough past medical records and kidney test results to complete the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called an ACE inhibitor (a type of blood pressure drug) in people with early-stage Alport syndrome, a genetic kidney condition. The goal is to see if it can protect kidney function and reduce protein in urine, before kidney damage gets worse.
This study follows people diagnosed with Alport syndrome to better understand the condition and its effects. It may help researchers learn what to watch for over time and how the disease progresses.
This is a registry that collects information from people with Alport syndrome to better understand the disease and how to delay kidney failure. It may help researchers learn which factors and treatments are most important over time.
This registry collects health information from people with Alport syndrome to help researchers better understand the condition and improve future treatments.
This study tests if stem cells from umbilical cord blood can help children aged 3 to 12 with Alport syndrome, a genetic kidney disease. It aims to slow kidney damage and improve function.
This study tests an experimental medicine for people with Alport syndrome caused by a specific type of gene change (nonsense mutation). The drug may help reduce protein in the urine and slow kidney decline. It is a blinded study, so you won't know if you get the real drug or a placebo.
Hear when a new Alport Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.